Mini-agrin prevents calcium leakage and restores the dystrophin complex

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Muscle cell death in muscular dystrophies depends upon calcium ion (Ca ++ ) leakage through sarcolemma and sarcoplasmic reticulum, triggered by muscle stretch during eccentric contraction.

We show here that Ca ++ spikes are detected in dystrophic myogenic cells in culture since early differentiation, before sarcomere assembly and contraction. Healthy and genetically corrected dystrophic myotubes do not display Ca ++ spikes which are blocked by co-culturing DMD myogenic cells with embryonic mouse motoneurons or treating them with agrin proteoglycan. Same effect is elicited by a muscle spliced, COOH peptide of agrin (termed here mini-agrin) that interacts with dystroglycan, favouring its binding to the basal lamina.

Lack of dystrophin in DMD myotubes results in decreased expression of Ca V 1.1 (CACNA1S), a Ca ++ sensor component of the Dihydropyridine Receptor (DHPR) complex, known to regulate Ryanodine Receptor 1 (RyR1). These events explain the emergence of Ca ++ spikes. Mini-agrin addition to medium, or lentivector-mediated mini-agrin expression in transplanted cells in vivo, stabilize the expression of Ca V 1.1 on the membrane. This leads to disappearance of Ca ++ spikes and to reappearance of α-dystroglycan, α-sarcoglycan and n-NOS, indicating the reconstitution of the dystrophin complex in the absence of dystrophin. These findings unveil a novel regulatory mechanism and offer a new therapeutic opportunity for targeting calcium ion influx as a co-treatment strategy.

Article activity feed